Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal



APRIL 23, 2014

Pharmatest to attend 2014 OARSI World Congress

Pharmatest will be attending the 2014 OARSI World Congress in Paris, France on April 24-27, 2014.

Pharmatest attends the congress with a scientific presentation that characterizes the effects of intra-articular rhBMP-7 treatment on the development of posttraumatic OA.

Presentation: Intra-articular treatment with recombinant human bone morphogenetic protein 7 (BMP-7) attenuates the development of osteoarthritis in a surgically induced rat model.

If you would like to meet our representative during the meeting, please click here.